Research Report on Methicillin-Resistant Staphylococcus Aureus Drugs MarketTrends and Forecast 2012 - 2018
Albany, NY (PRWEB) May 14, 2014 -- Methicillin-resistant staphylococcus aureus (MRSA) infections are caused due to Staphylococcus aureus bacterium that infect different parts of the body. These infections are difficult to treat due to high degree of resistance of these pathogens to the most commonly used antibiotics such as methicillin, amoxicillin, penicillin and oxacillin. The bacterium infects different parts of the body namely, skin, surgical wounds, blood streams, lungs, IV or other sites where the tubes such as catheters enter the body or the urinary tract and cause infection which can be life threatening.
Browse the full report with request TOC at
http://www.transparencymarketresearch.com/mrsa-drugs-market.html
MRSA infection is known to spread by casual contact or through contaminated objects called community associated MRSA (CA MRSA). It may also be acquired in hospitals or health care settings - healthcare associated MRSA (HA MRSA) is the most common form of MRSA infection. Community associated methicillin resistant S. aureus (CA-MRSA) infections are different from healthcare associated methicillin resistant S. aureus (HA-MRSA) considering their epidemiology and the characteristics of the strains which causes the infection. Overuse of antibiotics and use of potent drugs for less serious infections may also cause development of MRSA. The symptoms of infection depend on the site of infection and it can be diagnosed by laboratory testing.
One of the major drivers contributing to the market growth for MRSA drugs is increase in the prevalence of MRSA infections. In addition, growth in the government and non-government awareness programs has also become a key factor in improving the market growth. However, overcoming the tendency of pathogen for developing resistance to multi-drugs and increase in competition between the generic market players could impose a challenge to the market growth.
Free PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1315
MRSA can be usually treated by antibiotics such as bactrim and vancomycin, though, the pathogen has started developing resistance for these drugs, too, owing to its constant adapting power to newly developed antibiotics. Other options for the treatment of MRSA infection are generics such as clindamycin and minocycline, and prime brand-names such as Tygacil, Cubicin, Zyvox, and Synercid. Some of these antibiotics are only available intravenously. The most effective way of controlling the spread of MRSA is practicing basic hygiene such as use of disposable gloves, washing hands before making direct contact with patients as well as proper wound care.
Geographically, North America leads this market and is followed by Europe. However, increase in the development of healthcare infrastructure in emerging economies forecasts growth in demand for MRSA drugs in Asia-Pacific and other parts of the world. Some of the major players in this market include Takeda Pharmaceutical Company Limited, Merck & Co., Inc, AstraZeneca PLC, GlaxoSmithKline PLC, Pfizer, Inc., Cubist Pharmaceuticals, Inc., ViroPharma, Inc., Forest Laboratories, Inc., and Theravance, Inc.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments
Browse More Market Reports:-
http://technologyandmediaresearch.blogspot.co.uk/
http://pharmaceuticalresearchreport.blogspot.com
http://mrreports.wordpress.com/
http://sandyresearcher.wordpress.com/
http://marketresearchmoz.wordpress.com/
Sheela AK, Transparency Market Research, http://www.transparencymarketresearch.com, +1 (518) 618-1030, [email protected]
Share this article